Contineum Therapeutics (CTNM) Other Gross PP&E Adjustments (2023 - 2025)
Contineum Therapeutics has reported Other Gross PP&E Adjustments over the past 3 years, most recently at -$4.8 million for Q3 2025.
- Quarterly results put Other Gross PP&E Adjustments at -$4.8 million for Q3 2025, down 2354.82% from a year ago — trailing twelve months through Sep 2025 was -$4.8 million (down 2354.82% YoY), and the annual figure for FY2024 was -$3.9 million, down 744.85%.
- Other Gross PP&E Adjustments for Q3 2025 was -$4.8 million at Contineum Therapeutics, up from -$5.2 million in the prior quarter.
- Over the last five years, Other Gross PP&E Adjustments for CTNM hit a ceiling of $602000.0 in Q4 2023 and a floor of -$5.4 million in Q1 2025.
- Median Other Gross PP&E Adjustments over the past 3 years was -$3.3 million (2024), compared with a mean of -$2.7 million.
- Peak annual rise in Other Gross PP&E Adjustments hit 91.79% in 2025, while the deepest fall reached 2354.82% in 2025.
- Contineum Therapeutics' Other Gross PP&E Adjustments stood at $602000.0 in 2023, then crashed by 744.85% to -$3.9 million in 2024, then dropped by 24.57% to -$4.8 million in 2025.
- The last three reported values for Other Gross PP&E Adjustments were -$4.8 million (Q3 2025), -$5.2 million (Q2 2025), and -$5.4 million (Q1 2025) per Business Quant data.